Tandem Diabetes Care | TNDM - Interest Expense On Debt


Tandem Diabetes Care reported $1.15B in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Accuray USD 2.88M 72K Dec/2024
Align Technology USD 9.96M 3.02M Jun/2026
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 64M 14M Jun/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Boston Scientific USD 100M 4M Sep/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dexcom USD 3.1M 100K Sep/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Eli Lilly USD 316M 201.3M Sep/2026
Globus Medical USD 5.49B 48.7M Jun/2026
ICU Medical USD 18.53M 2.11M Mar/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.96M 33K Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 186M 10M Jun/2026
Merit Medical Systems USD 7.33M 4.78M Sep/2026
Orthofix International 4.68M 731K Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026